Allergy Therapeutics Plc
(OTC) AGYTF
Allergy Therapeutics Plc Financials at a Glance
Market Cap
$949.88M
Revenue (TTM)
£122.41M
Net Income (TTM)
-£84.56M
EPS (TTM)
-$0.01
P/E Ratio
-11.54
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.15
Volume
7,142
Open
$0.15
Price
$0.15
Volume
7,142
Open
$0.15
Previous Close
$0.15
Daily Range
$0.15 - $0.15
52-Week Range
$0.09 - $0.15
Estimated Earnings Date
Sep 30, 2026
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.15
Volume
7,142
Open
$0.15
Previous Close
$0.15
Daily Range
$0.15 - $0.15
52-Week Range
$0.09 - $0.15
Estimated Earnings Date
Sep 30, 2026
AGYTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allergy Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
612
CEO
Manuel Llobet, MBA
Website
www.allergytherapeutics.comHeadquarters
Worthing, BN14 8SA, GB
AGYTF Financials
Key Financial Metrics (TTM)
Gross Margin
41.17%
Operating Margin
-60.23%
Net Income Margin
-85.46%
Return on Equity
409.00%
Return on Capital
-131.69%
Return on Assets
-68.96%
Earnings Yield
-8.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$949.88M
Shares Outstanding
6.33B
Volume
7.14K
Avg. Volume
937.774
Financials (TTM)
Gross Profit
£59.40M
Operating Income
-£57.90M
EBITDA
-£63.73M
Operating Cash Flow
-£61.77M
Capital Expenditure
-£7.87M
Free Cash Flow
-£69.64M
Cash & ST Invst.
£10.08M
Total Debt
£26.75M
Allergy Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£36.27M
+8.0%
Gross Profit
£19.32M
-5.9%
Gross Margin
53.26%
N/A
Market Cap
$949.88M
N/A
Market Cap/Employee
$1.55M
N/A
Employees
612
N/A
Net Income
-£19.91M
-27.2%
EBITDA
-£9.76M
-4.4%
Quarterly Fundamentals
Total Cash
£10.08M
-25.4%
Total Debt
£26.75M
+171.6%
Accounts Receivable
£10.98M
+10.5%
Inventory
£13.79M
+15.9%
Long Term Debt
£24.79M
+206.0%
Short Term Debt
£1.96M
+12.2%
Return on Assets
-68.96%
N/A
Return on Invested Capital
-88.54%
N/A
Free Cash Flow
-£14.51M
-14.8%
Operating Cash Flow
-£11.71M
-8.7%